AI-generated summary
The authors surveyed US dermatologists and plastic surgeons who use laser and energy devices for facial rejuvenation about their pre- and postprocedure measures. Of 58 respondents (a 19.3% response rate), 96% reported prophylactic oral antiviral use, but practices varied in timing and duration, as well as in skin preparation, wound care and sun protection. The authors note this inconsistency calls for evidence-based recommendations.
- Participants
- 58
- Who or what was studied
- US dermatologists and plastic surgeons practicing medical esthetics who use laser and other energy devices for facial rejuvenation
- Limits stated in the abstract
- The survey had a low 19.3% response rate (58 of 300 invited physicians), so results may not represent all practitioners.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.